Education
About Us
Working with TipRanks
Follow Us
Warwick Bonner Tong Insider Profile
4 Followers
Warwick Bonner Tong, Director at Amplia Therapeutics, holds 3.71M shares in Amplia Therapeutics (Ticker: INNMF). Most recently, Warwick Bonner Tong Bought $695,652 shares of Amplia Therapeutics on Dec 20, 2024 for an estimated value of 80.00K.
Warwick Bonner Tong Amplia Therapeutics (INNMF)Director
Amplia Therapeutics (INNMF)
Director
Ranked #2,484 out of 102,551 Corporate Insiders
Profitable Transactions
5 out of 7 Profitable Transactions
Average Return
+74.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Warwick Bonner Tong's holdings
Insider Roles
Director
Roles that Warwick Bonner Tong holds in companies
Most Profitable Insider Trade
The most profitable trade made by Warwick Bonner Tong
Warwick Bonner Tong's Trading History
List of latest transactions for each holding click on a transaction to see Warwick Bonner Tong's performance on stock
You May Also Like
Warwick Bonner Tong insider profile FAQ
What is the percentage of profitable transactions made by Warwick Bonner Tong?
The percentage of profitable transactions made by Warwick Bonner Tong is 71%.
What is the average return per transaction made by Warwick Bonner Tong?
The average return per transaction made by Warwick Bonner Tong is 74.90%.
What stocks does Warwick Bonner Tong hold?
Warwick Bonner Tong holds: INNMF stocks.
What was Warwick Bonner Tong’s latest transaction?
Warwick Bonner Tong latest transaction was an Informative Buy of $80.00K.
What was Warwick Bonner Tong's most profitable transaction?
Warwick Bonner Tong’s most profitable transaction was an Informative Buy of INNMF stock on December 20, 2024. The return on the trade was 283.30%.
What is Warwick Bonner Tong's role in Amplia Therapeutics?
Warwick Bonner Tong's role in Amplia Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.